Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine
- 1 January 1992
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 31 (3), 200-204
- https://doi.org/10.1007/bf00685548
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Myocardial damage induced by doxorubicins: Hydroperoxide-initiated chemiluminescence and morphologyFree Radical Biology & Medicine, 1990
- The role of iron in oxygen radical mediated lipid peroxidationChemico-Biological Interactions, 1989
- Effects of ICRF-187 on the cardiac and renal toxicity of epirubicin in spontaneously hypertensive ratsCancer Chemotherapy and Pharmacology, 1989
- Adriamycin Affects Glomerular Renal Function: Evidence for the Involvement of Oxygen RadicalsFree Radical Research Communications, 1989
- Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) ratsToxicology and Applied Pharmacology, 1988
- Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complexBiochemistry, 1982
- AdriamycinAnnals of Internal Medicine, 1974
- UV-Assay after Separation on DEAE-SephadexPublished by Elsevier ,1974
- Clinical Evaluation of Adriamycin, a New Antitumour AntibioticBMJ, 1969
- ‘Daunomycin’, a New Antibiotic of the Rhodomycin GroupNature, 1964